Yield of FDG PET/CT for Defining the Extent of Disease in Patients with Kaposi Sarcoma

Yield of FDG PET/CT for Defining the Extent of Disease in Patients with Kaposi Sarcoma

Background: Positron emission tomography/computed tomography with fluorodeoxyglucose (F-18) (FDG PET/CT) is increasingly used in Kaposi sarcoma (KS), but its value has not been assessed. Objectives: In this study, we aimed to evaluate the diagnostic accuracy of FDG PET/CT to define the extent of dis...

Full description

Bibliographic Details
Main Authors: Louise Pesqué, Julie Delyon, Coralie Lheure, Barouyr Baroudjian, Maxime Battistella, Pascal Merlet, Céleste Lebbé, Laetitia Vercellino
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Cancers
Subjects:
F-18-Fluorodeoxyglucose
positron emission tomography/computed tomography
Kaposi sarcoma
disease staging
diagnostic accuracy
Online Access:https://www.mdpi.com/2072-6694/14/9/2189

Internet

https://www.mdpi.com/2072-6694/14/9/2189

Similar Items